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Available online xxxxObjectives: Athletes performing sports on high level are at increased risk for sudden cardiac death. This includes
paediatric athletes, even though data on screening strategies in this age group remain scarce. This study aimed to
assess electrocardiogram interpretation criteria in paediatric athletes and to evaluate the cost of screening.
Methods: National, multicentre, retrospective, observational study on 891 athletes of paediatric age (<18 years)
evaluated by history, physical examination and 12-lead electrocardiogram. The primary outcome measure was
abnormal electrocardiogram findings according to the International Recommendations for Electrographic Inter-
pretation in Athletes. The secondary outcome measure was cost of screening.
Results: 19 athletes (2.1%) presented abnormal electrocardiogram findings requiring further investigations,
mainly abnormal T-wave inversion. These 19 athletes were predominantly males, performing endurance sports
with amean volume of 10weekly hours for a mean duration of 6 years of training. Further investigations did not
identify any relevant pathology. All athletes were cleared for competition with regular follow-up. Total costs of
the screening were 108,860 USD (122 USD per athlete).
Conclusions: Our study using the International Recommendations for Electrographic Interpretation in Athletes iden-
tified a lowcount of abnormalfindings in paediatric athletes, yet raising substantially the cost of screening.Hence, the
utility of electrocardiogram-inclusive screening of paediatric athletes remains to be elucidated by longitudinal data.
© 2021 The Authors. Published by Elsevier Ltd on behalf of Sports Medicine Australia. This is an open access article





Sudden cardiac deathPractical implications
• Of the 891paediatric athletes (mean age 14 years), 3.8% had abnormal
findings, identified by history, physical examination and 12-lead elec-
trocardiogram (ECG).
• 2.1% presented abnormal ECG findings according to the Interna-
tional Recommendations for Electrographic Interpretation in.
on behalf of Sports Medicine Austral
bade, A. Menafoglio, et al., D
and Medicine in Sport, https:Athletes, resulting in a low rate of subsequent downstream inves-
tigations.
• Subsequent assessment failed to identify any pathology questioning
the utility of general ECG screening in the paediatric age range.
• The cost of screening was 122 USD per athlete.
1. Introduction
Pre-participation screening for athletes continues to be a matter of
debate. Often cited arguments against routine electrocardiogramia. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
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24 h-Holter monitoring 205.63
Exercise testing 165.21
Cardiac MRI 742.21
24 h-blood pressure monitoring 92.42
ECG with pharmacological exposure 163.95
ECG, electrocardiogram; MRI, magnetic resonance imaging.
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sitivity and specificity, cost, difficulties with quality control and ethical
issues.1 ECG criteria have been revised several times with the last ver-
sion being published in 2017.2 They now achieve high values of specific-
ity and sensitivity in adults.3 However data on paediatric athletes are
sparse. A study from the Middle East cited a false-positive rate of 6.8%.4
During childhood and adolescence, the heart is continuously devel-
oping. Major steps in cardiovascular growth and development occur
during puberty, resulting in slightly less pronounced cardiac adapta-
tions to exercise in pre-pubertal athletes.5,6 It therefore remains to elu-
cidate whether diagnostic ECG criteria targeting adult athletes can be
applied to the paediatric population. A meta-analysis demonstrated
that paediatric athletes gather more training related and training unre-
lated ECG changes than non-athletes.7 These modifications are mainly
influenced by chronological age and ethnicitywithmore changes in ath-
letes older than 14 years and of Afro-Caribbean ethnicity.7 Male sex im-
pacts on the prevalence of both, training-related and abnormal ECG
changes in athletes of paediatric and adult age.8,9
Hence, this study aimed to determine the performance of the Inter-
national Recommendations for Electrographic Interpretation in
Athletes2 in a paediatric population and to investigate the financial im-
plications of this screening program. We hypothesised that due to the
phenotypical emergence of SCD related disease with age, the rate of ab-
normal electrocardiographic findings in paediatric athletes would be
lower compared to adult data with subsequently higher costs per find-
ing.
2. Methods
We enrolled 891 athletes between 2011 and 2017 undergoing sin-
gle, first-time preparticipation cardiovascular screening from six medi-
cal centres in Switzerland: Lausanne, Bern (in collaboration with the
Swiss Federal Institute of Sports Magglingen), Geneva, Zurich, Bellin-
zona and Lugano. Inclusion criteria included age less than 18 years,
sport participation at an international, national or regional level, and
minimal training frequency of 6 h per week. We excluded individuals
with known heart disease. The Swiss Ethics Committee approved the
study protocol (Project No 2018-00121). Given the fact that the partic-
ipants were included retrospectively, the Swiss Ethics Committee de-
clared that no retroactive consent of the single participants was
required.
The following parameterswere collected: age, sex, ethnicity, weight,
height, body mass index (BMI), body fat mass, sport type, training vol-
ume inweekly hours, duration in years of training, level of performance,
sports category according to the Mitchell criteria,10 personal and family
medical history, physical examination, resting heart rate and resting
blood pressure.
Medical history consisted of screening for cardiovascular symptoms
such as chest pain, palpitation, dyspnoea and prior syncope. Family his-
tory included structural heart disease, primary arrhythmia and sudden
cardiac death (SCD). Physical examination aimed at the detection of
Marfanoid features, arterial hypertension, cardiac murmurs, and aortic
coarctation. Arterial hypertension was defined as proposed by the
American Academy of Pediatrics.11
A 12-lead ECG was performed and analysed by the treating sports
physician and/or cardiologist. All ECGs were reviewed in each centre
by an experienced sports cardiologist. ECG analysis aimed to differenti-
ate normal ECGadaptations frompatterns suggestive of disease andwas
retrospectively analysed according to the International Recommenda-
tions for Electrocardiographic Interpretation in Athletes.2
Athletes with abnormal medical history, physical examination or
ECG findings (two borderline or one abnormal) were subject to further
investigations at the discretion of the treating physician, including
transthoracic echocardiography, 24h-Holtermonitoring,maximal exer-
cise stress testing, cardiac magnetic resonance imaging (MRI), 24 h
blood pressure monitoring or ECG with pharmacological exposure. In2
cases where criteria for borderline or abnormal ECG findings were
equivocal, the ECG was repeated on a different appointment. Further
cardiology work-up was only performed if the initial finding could be
reproduced. Even though ECG analysis by the time of medical consulta-
tion relied on the use of contemporary ECG criteria, retrospective anal-
ysis by the International Recommendations for Electrographic
Interpretation in Athletes in our study did not show any case of false-
positive ECG findings based on less specific prior criteria, requiring un-
necessary secondary examinations. In each study centre, the need for
follow-up testing was determined by the consulting physicians and
was not standardised. Exclusion from sports participation was based
on additional examinations and shared decision making involving the
treating physician, a cardiologist and/or a paediatric cardiologist.
Costs were calculated in Swiss francs according to the data of
Menafoglio12 and are depicted in USD (conversion rate 1 US dollar =
0.95 Swiss franc) in Table 1.
Values are presented as either percentage or median with inter-
quartile range [IQR]. In order to test the influence of quantitative vari-
ables on the percentage of ECG abnormalities, we used one-way
ANOVA followed by Bonferroni multiple comparison procedure; or
Kruskal-Wallis test followed by Dunn's test with Bonferroni procedure,
if normality assumptions were not verified. For the influence of qualita-
tive variable, aswe expected small numbers of ECG abnormalities in our
cohort, we used the Fisher's exact test for 2 × 2 tables and the Pearson
χ2 test otherwise. Values of p< 0.05were considered statistically signif-
icant. All statistical analysis was performed using NCSS (Number
Cruncher Statistical System. 2013: Atlanta).
3. Results
We included 891 athletes with a mean age of 14.8 ± 1.6 (SD) years
(range 8 to 17). Approximately two-thirds of the cohort were males
(580; 65%) and nearly all were of Caucasian ethnicity (864; 97%). The
45 different sports represented all nine categories of the Mitchell
classification.10 High-dynamic moderate-static class sports (IIC) (366;
41%), and high-dynamic low-static class sports (IC) (194; 22%) ac-
counted for the majority of athletes. Football was the most common
single sport represented (158; 18%). The athletes performed on interna-
tional (22%), national (34%) and regional (44%) level of competition.
Training time was 10.8 ± 5.3 (SD) h per week and training duration
was 6.5 ± 2.7 (SD) years.
History revealed cardiac symptoms in 15 athletes (1.7%) as follows at
rest and/or with exertion: chest pain (n = 7), palpitation (n = 3), prior
syncope (n=3) and dyspnoea (n=2). Family history of first-degree rel-
atives was positive in 15 athletes (1.7%), thereof premature cardiac death
(n=1), dilated cardiomyopathy (n=1) andBrugada syndrome (n=1).
Physical examination detected abnormalities suggestive of underlying
cardiovascular disease in 19 athletes (2.1%) with the following findings:
cardiac murmur (n = 10), arterial hypertension (n = 8), and irregular
Table 2
Detailed cohort characteristics of athletes with abnormal ECG findings.
Age Sex Ethnicity ECG
criteria









1 16 Male Caucasian TWI, STD 21.8 50–75 11 8 Football Mixed Echo, Ex, H, MRI Not available
2 12 Female Caucasian TWI 16.0 10 6 7 Football Mixed Echo 1 year (ECG): normal
3 14 Male Caucasian TWI 17.7 10–25 6 1 Football Mixed Echo, Ex Not available
4 16 Male Caucasian TWI 24.8 75–90 10 5 Running Endurance Echo, Ex, H, MRI Not available
5 16 Male Caucasian TWI 19.8 25–50 11 4 Judo Power Echo, Ex, H 7 years (ECG): normal
6 16 Male Caucasian TWI 22.9 75 12 7 Ice Hockey Mixed Echo 9 years (ECG, Echo, Ex, H, MRI):
LVWT max. 14 mm
7 12 Female Caucasian TWI 18.4 50–75 12 8 Karate Power Echo 4 years (ECG): normal
8 16 Male Caucasian TWI 19.0 10–25 12 5 Triathlon Endurance Echo, MRI 2 years (ECG): normal
9 13 Female Caucasian PQW 21.7 75–90 15 3 Volleyball Mixed Follow-up ECG Not available
10 14 Male Caucasian PQW 16.6 3–10 8 6 Football Mixed Follow-up ECG 3 years (ECG): normal
11 13 Male Caucasian PQW 20.7 50–75 9 3 Alpine skiing Power Follow-up ECG 2 years (ECG): normal
12 14 Female Caucasian PQT 21.9 75–90 7 5 Cross-country skiing Endurance Follow-up ECG 3 years (ECG): normal
13 14 Male Caucasian ≥2 PVCs 18.7 25–50 6 1 Fencing Mixed Echo, Ex, H 1 year (ECG, Ex): normal
14 14 Male Caucasian ≥2 PVCs 18.7 25–50 6 6 Football Mixed Echo, Ex, H 8 years (ECG, Echo, Ex, H): normal
15 16 Male Asian ≥2 PVCs 18.4 10–25 15 8 Badminton Mixed Echo, H 4 years (ECG; Echo, Ex, H, MRI,
implantable cardiac monitor,
EP study): AVNRT
16 13 Male Caucasian ≥2 PVCs 18.5 25–50 8 6 Cross-country skiing Endurance Echo, Ex, H 3 years (ECG, H): normal
17 10 Female Caucasian ≥2 PVCs 19.4 75–90 24 8 Gymnastics Mixed Follow-up ECG 5 years (ECG): normal
18 15 Male Caucasian RAD, RBBB 19.1 25–50 13 9 Football Mixed Follow-up ECG 2 years (ECG): normal
19 16 Male Caucasian RAD, RBBB 20.5 25–50 12 8 Football Mixed Follow-up ECG 1 year (ECG): normal
Age in [years]. AVNRT, atrio-ventricular nodal re-entry tachycardia; BMI, bodymass index; Echo, transthoracic echocardiography; EP study, electrophysiological study; Ex, exercise stress
test; H, Holter ECG; LVWT, Left ventricular wall thickness; MRI= cardiac magnetic resonance imaging; P, percentile (WHO); PQT, prolonged QT interval; PQW, pathologic Q-waves; PVC,
premature ventricular contractions; RAD, right axis deviation: RBBB, right bundle branch block; STD, ST-segment depression; TWI, T-wave inversion (excluding juvenile pattern).
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examination. Three athletes had abnormal history and family history.
Four athletes had abnormal family history and physical examination.
Overall, there were 36 athletes identified without ECG.
Of the 891 athletes, 672 (75.4%) demonstrated normal findings on
standard 12-lead ECG according to the International Recommendations
for Electrographic Interpretation in Athletes, thereof 12.8% a juvenile
pattern, i.e., T-wave inversion in leads V1–V3 under the age of 16
years. Thirty-eight (4.3%) fulfilled borderline criteria. Only two (0.2%)
of them had two borderline criteria requiring further investigations.
17 (2.1%) athletes presented at least one abnormal finding as detailed
below. Of the 36 athletes with abnormal history and physical examina-
tion, three had one borderline finding and two had an abnormal ECG
finding. 21 of the 36 athletes with abnormal history and physical exam-
ination were not further investigated, since the abnormal findings were
not suggesting severe disease. Overall, 34 (3.8%) athletes were deemed
to require post-screening investigation after integration of data from
medical history, physical examination, and 12-lead ECG.
The 2 athleteswith two borderlinefindings presented both right axis
deviation and complete right bundle branch block (RBBB). Of the 17
athletes with abnormal findings, 8 (47%) had isolated T wave inversion
while only 1 had two abnormal criteria: T wave inversion and STTable 3
Demographic, anthropometric, sport-related and clinical data of athletes classified by ECG find
Athletes.2 Note that two borderline findings were defined as abnormal ECG.
No ECG findings (n = 164) Training-related ECG (n =
Age [years] 14.6 ± 1.7 14.8 ± 1.5
Weight [kg] 58.0 ± 13.1 58.5 ± 12.3
Height [cm] 167.1 ± 11.6 168.3 ± 11.0
BMI [kg/m2] 20.5 ± 2.7 20.4 ± 2.5
Body fat [%] 19.0 ± 6.3 17.2 ± 6.5
Weekly hours 9.9 ± 5.1⁎ 11.1 ± 5.5⁎
Years of training 6.3 ± 2.9 6.6 ± 2.6
HR [bpm] 70.0 ± 8.0⁎ 63.5 ± 10.1⁎
BP syst [mm Hg] 114.7 ± 11.0 116.6 ± 9.7
BP dias [mm Hg] 66.4 ± 8.5 65.1 ± 8.5
BP mean [mm Hg] 82.8 ± 8.1 83.5 ± 8.7
BMI, body mass index; BP, blood pressure; dias, diastolic; syst, systolic; HR, heart rate.
⁎ Statistically significant (p < 0.05) between subgroups.
3
segment depression. The remaining abnormal findingswere distributed
as follows: premature ventricular contractions (n= 5; 29%), pathologic
Q waves (n= 3; 18%) and prolonged QT interval (n= 1; 6%) (Table 2).
All but one of the athletes with abnormal findings on ECG (two bor-
derline or one abnormal) were of Caucasian ethnicity. Thirteen of the 19
athletes with abnormal ECG were males (68%) resulting in a similar
male–female ratio compared to the whole cohort (65% male). The con-
cerned athletes performed in 12 different types of sports. The predom-
inant type of sport was football with 37% and thus twice more
represented than in the whole cohort (18%).
When comparing athletes without ECG findings, training-related
ECG, one borderline finding and abnormal ECG (including individuals
with 2 borderline findings), the only differenceswere found for training
volume and heart rate of athletes without ECG findings compared to
training-related ECG (Table 3). When separating by age, we used a
cut-off of 15 years to determine post-pubertal athletes, since Tanner
stages were not available retrospectively. Athletes older than 15 years
presented greater training volume (10.9 ± 5.3 vs 10.5 ± 5.4, p <
0.05) and duration of training (7.1 ± 2.7 vs 5.6 ± 2.5, p < 0.05).
Among the athletes with abnormal personal or family history and/or
physical examination but with normal ECG, further examinations were
performed in 15 athletes including transthoracic echocardiographyings according to the International Recommendations for Electrographic Interpretation in
672) 1 borderline ECG finding (n = 36) Abnormal ECG (n = 19)
14.4 ± 1.9 14.6 ± 1.8
59.3 ± 15.2 55.9 ± 11.2
170.7 ± 13.6 167.9 ± 11.3
19.9 ± 2.8 19.6 ± 2.1
18.2 ± 6.0 16.7 ± 5.0
9.7 ± 3.1 10.5 ± 4.3
5.9 ± 2.7 5.9 ± 2.3
65.6 ± 10.4 64.4 ± 10.3
116.9 ± 11.8 115.0 ± 10.0
65.9 ± 10.2 65.9 ± 7.7
86.6 ± 14.1 89.5 ± 13.1
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=2), ECGwith ajmaline challenge (n=1), and 24 h-Holter monitor-
ing (n = 1). No pathology was detected in any of these 15 athletes
and all were cleared for sports participation.
The 19 athletes with abnormal ECG findings underwent trans-
thoracic echocardiography (n = 12), 24 h-Holter (n = 7), exercise
testing (n = 7) and cardiac MRI (n = 3). Athlete 8 (Table 2) with
pathologic T wave inversion was found to have medio-mural apical
fibrosis of the left ventricle onMRI which was considered an unspe-
cific finding but could be suggestive of former myocarditis in an
atypical localisation. Athlete 3 with pathologic T wave inversion
had a mild posterior leaflet mitral prolapse with minimal insuffi-
ciency. Among the remaining 6 athletes with pathologic T wave in-
version, including the one with additional ST segment depression,
no diagnosis was established after comprehensive testing. Among
the 5 athletes with premature ventricular contractions, no underly-
ing cardiovascular disease was found. The remaining findings such
as pathologic Q waves (n = 3), prolonged QT interval (n = 1), and
two borderline ECG criteria (n = 2) could not be reproduced on
follow-up ECG and long QT syndrome was ruled out. Consequently,
no athletes in our cohort were excluded from competitive sport
participation.
Follow-up data for athletes with abnormal history, physical ex-
amination and/or ECGwere available for 24/34 (71%) of affected in-
dividuals with a mean duration of 3.8 years. Athlete 6 has been
followed until now and recently had a wall thickness of maximally
14 mm. He was allowed to continue his sport with annual follow-
up. Athlete 15 has been investigated for four years due to ventricu-
lar extrasystoles and a positive family history (premature SCD of
his father). A recent electrophysiological study was performed be-
cause of palpitations and wide complex tachycardia on implantable
cardiac monitor. It showed atrioventricular nodal re-entrant tachy-
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1 Exercise stress test
1 Holter
Costs: 699 USD
Fig. 1. Abnormal findings identified by history, physical examin
Echo, transthoracic echocardiography; Ex, exercise stress test; H
4
Costs for basic screening of the 891 athletes amounted to 96,416
USD (108 USD per athlete): history-taking 31,232 USD, clinical exami-
nation 39,907 USD, and 12-lead ECG 25,276 USD. Further examinations
because of ECG findings increased the costs to 105,180 USD (118 USD
per athlete). Further examinations because of abnormal history and
physical examination amounted to 4157 USD (115 USD per athlete)
(Fig. 1). Thus, the total costs of the program were 109,025 USD (122
USD per athlete). Screening confined to history and physical examina-
tionwould have decreased the costs to 75,297USD (85 USD per athlete)
for basic screening excluding 12-lead ECG and further investigations.
The cost of post-screening investigations for the 19 athletes with
ECG included: transthoracic echocardiography = 3942 USD, exercise
testing = 1156 USD, 24 h-Holter monitoring = 1439 USD, and cardiac
MRI=2227USD. This represented 10USDper athlete or 461USDper ath-
lete with abnormal ECG. Since there were no diagnoses associated with
sudden cardiac death (SCD), costs per finding could not be calculated.
4. Discussion
This studywas designed to determine the diagnostic yield andfinan-
cial implications of ECG-inclusive screening among paediatric competi-
tive Swiss athletes. Keyfindings can be summarised as follows: First, the
rate of abnormal ECG findings basedupon the International Recommen-
dations for Electrographic Interpretation in Athletes requiring further
investigations was low amounting to 2.1%. Second, none of the further
evaluated athletes were diagnosed with an SCD related pathology.
Thus, all athletes were cleared for competition. Third, ECG inclusion
raised the costs per athlete by more than 30% compared to a screening
program based on history and physical examination.
The guidelines of the Swiss Society of Sports Medicine for athletes
screening were published first in 1998 and reinforced in 2010.13 They
target athletes above 14 years and suggest preparticipation screening
















ation and/or 12-lead ECG with cost calculation.
, Holter ECG; MRI = cardiac magnetic resonance imaging.
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two thirds of all cases.14
History and physical examination remain the cornerstones of athlete
screening. Nevertheless, at least 60% of conditions predisposing to SCD
in young athletes are detected on ECG.15,16 ECG screening is superior
to history and physical examination in the detection of SCD-associated
disease.17 In contrast, the global incidence of sports-related SCD in ath-
letes is low.18 This implies a risk for inappropriate restriction of athletes
with false-positive results.19 The Swiss guidelines currently follow the
European recommendations that include routine screening with
ECG.20 The recently published Canadian statement is an intermediary
approach that argues against routine ECG and suggests a tiered ap-
proach in evaluating athletes.19 It limits ECG to athletes with positive
findings in history and physical examination.19 Consequently, costs
are reduced at the price of a higher rate of missed SCD related diseases.
If ECG screening is still a matter of debate in the adult population,
there is no established strategy for children yet. With only 2.1% of abnor-
mal ECG in our cohort we can conclude that the false positive rate is low
and similar to older athletes.21,22 In addition, the fact that non-invasive
additional investigations allowed to clear all athletes is encouraging.
Data from other studies on paediatric athletes confirm the trend of a
low rate of abnormal findings in athletes under 18 years: Calo demon-
strated in Italian male paediatric football players 2.9% of abnormal
ECG.23 In football players aged 15 to 17 years from the UK, the rate of
SCD related cardiac disorders was 0.38%.24 This suggests that adult diag-
nostic criteria can be used in children without an unacceptable amount
of false positive results. However, a study on paediatric athletes from
the Middle East identified 8.2% of abnormal findings by ECG.4 Of note,
this study was performed in athletes from different ethnic backgrounds
who are known to exhibit more abnormal ECG findings.25 Given the
lack of generalised follow-up in our cohort and the absence of universal
imaging to exclude or detect occult disease we cannot comment on sen-
sitivity and false negative rate. Nevertheless, the International Recom-
mendations for Electrographic Interpretation in Athletes achieved high
accuracy rates in adolescent football players.26
None of the 891 athletes screened had a diagnosis associated with
SCD. It therefore raises the question whether ECG screening is efficient
in the paediatric population. The heart continues to develop during
growth and ECG reflects dynamic changes during this period. Structural
heart diseases are conditions that develop with age. Hypertrophic
cardiomyopathy (HCM) and arrhythmogenic right ventricular cardio-
myopathy (ARVC) are the most frequent SCD related structural
diseases.27 The genetic predisposition to develop these conditions is
present at birth, but the morphological and electrical manifestation
are often absent in children and young adults. This may require regular
ECG in the screening strategy of this population. The best example for
the emergence of cardiomyopathies with age is shown by athlete num-
ber 6 from Table 2. Based on his initially abnormal ECG, it took nine
years of yearly follow-up to identify a left ventricular wall thickness
(14 mm) which raised the suspicion of HCM, yet not confirmed. Of
note, serial screening proved to increase the diagnostic yield of SCD re-
lated conditions by factor three compared to single screening.28
It is worth to mention that the incidence of inherited heart disease
varies between different countries. In the Italian study that had pre-
sented a decline of 89% in SCD after implementation of a mandatory
ECG-inclusive screening for athletes, ARVC was the predominantly
diagnosed condition.29 Populations of other countries, like the US,
seem to bare another genetic profile with HCMbeing themost common
identified cause for SCD in the young athlete.14 In a study on SCD in
Switzerland, HCM was also the major cardiomyopathy.30 These
geographical differences need to be taken into account before imple-
menting a general screening program in a paediatric population. It is
not appropriate to screen children for a condition that does notmanifest
before adulthood. However, in recent series of SCD, the origin remained
predominantly undetermined with a structurally normal heart at
autopsy.315
All of the athletes were screened first by history and physical exam-
ination. Interestingly, between the 36 athletes with abnormal history
and physical examination and the 19 athletes with abnormal ECG,
there were only two overlapping. One may argue that limiting ECG
screening to athletes with positive history and physical examination
might have reduced our rate of false-positive findings, thus reducing
cost. However, the sensitivity of clinical parameters alone to detect sin-
ister conditions is insufficient.32 Even though SCD victimsmight present
cardiovascular symptoms before a fatal event,33 the majority of cases
occurs in the absence of symptoms.14 Besides, the training load of
young competitive athletes is equivalent to that reported in adults.5
Therefore, early identification of underlying (cardiac) disease also al-
lows guiding young individuals towards their future career.
As stated in the above-mentioned study by Malhotra on adolescent
football players in the UK, the rate of SCD related disorders on one-
time screening was very low.24 Comparable to our study, for 2% of ab-
normal findings on initial screening, no diagnosis could be established.
However, long-term follow-up (mean 10.6 years) demonstrated several
missed fatalities, resulting in an SCD-rate in screened athletes of 6.8/
100,000 athletes. We therefore believe that follow-up is of paramount
importance in screening athletes in the paediatric age range, notably
in post-pubertal individuals.
In this controversial debate on ECG inclusion, cost is often cited as an
additional concern: according to reports from the US, nationwide inclu-
sion of ECG would increase the costs to several billions of dollars.34
However, these calculations do not consider the increased sensitivity
and specificity of the most recent International Recommendations for
Electrographic Interpretation in Athletes.2 A study from the UK demon-
strated a 27% cost reduction by the International Recommendations for
Electrographic Interpretation in Athletes compared to the 2010 ESC
criteria.22 In 42% of abnormal history and physical examination in our
cohort, further investigations other than ECG were performed. This
contrasted to 63% in the group of abnormal ECGs who had at least one
further investigation. Even though ECG increases the absolute cost of
screening, it proved to be more cost-effective than history and physical
examination only.35–37
Another important factor to be considered is the timing of secondary
investigations, keeping athletes away from training and thus potentially
interfering with their sports career. In this ongoing debate, it should be
emphasised that screening young athletes, in addition to risk stratifica-
tion, offers a unique opportunity to address the specific issues of ath-
letes' health like injury prevention, overtraining, doping and to assess
potential problems of the adolescent population like eating disorders
or fatigue.
In this study, we respond to the urgent demand for more data on
ECG screening in young athletes.1 However, we admit several limita-
tions. Firstly, only athleteswhowere part of an organised screening pro-
gramwere included. Thismay cause a selection bias. Secondly, nearly all
athletes included were Caucasians. Thus, the often-addressed ethnical
impact on electrocardiographic findings could not be evaluated.7
Thirdly, due to the retrospective, multicentre nature of the study, we
did not use standardised medical history, physical examination or ECG
protocols and moreover referral and choice of further investigations
were based on local attitude. Fourthly, although this is one of the biggest
studies in elite paediatric athletes, still the number is small when con-
sidering the prevalence of SCD related conditions in young individuals,
reported as 1 in 300.38 Finally, we were unable to obtain follow-up
data in a significant proportion of athletes referred for further evalua-
tion, raising the possibility that we may have missed some diagnoses.
In conclusion, the low rate of abnormal ECG findings suggests that
adult criteria can be used in paediatric athletes. The lack of correlation
with the presence of relevant disease in a broad paediatric population
and the absence of diagnosis of SCD related conditions on single screen-
ingunderline the need for regular follow-up.With further investigations
taken into account, adding ECG to history and physical examination in-
creased the cost of screening from 85 to 122 USD. Our data may be
M. Albiński, M. Saubade, A. Menafoglio et al. Journal of Science and Medicine in Sport xxx (xxxx) xxxhelpful in the development of cardiac screening programs in paediatric
athletes. Future policy makers should carefully assess the diagnostic
yield and costs of individual screening modalities and adopt the most
cost-efficient strategy. Prospective follow-up data are needed to eluci-
date long-term evolution of these athletes starting their sports career
in early life.
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